Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 12:38 pm Purchase |
2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 3,431,010 4.900% |
57,550 (+1.71%) |
Filing History |
| 2022-02-14 12:37 pm Purchase |
2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
PFM Health Sciences, LP | 3,972,868 7.800% |
1,584,801 (+66.36%) |
Filing History |
| 2022-02-14 12:35 pm Unchanged |
2021-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
PFM Health Sciences, LP | 4,092,309 6.800% |
0 (Unchanged) |
Filing History |
| 2022-02-07 5:12 pm Purchase |
2022-01-27 | 13G | Sierra Oncology, Inc. SRRA |
PFM Health Sciences, LP | 1,062,888 5.500% |
1,062,888 (New Position) |
Filing History |
| 2021-08-06 5:04 pm Purchase |
2021-07-27 | 13G | Caribou Biosciences, Inc. CRBU |
PFM Health Sciences, LP | 4,092,309 7.200% |
4,092,309 (New Position) |
Filing History |
| 2021-02-16 4:10 pm Sale |
2020-12-31 | 13G | Journey Medical Corporation DERM |
PFM Health Sciences, LP | 0 0.000% |
-3,150,049 (Position Closed) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Outset Medical, Inc. OM |
PFM Health Sciences, LP | 194,080 6.800% |
2,548 (+1.33%) |
Filing History |
| 2021-02-16 4:10 pm Unchanged |
2020-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 3,373,460 5.200% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
PFM Health Sciences, LP | 2,814,363 6.000% |
382,864 (+15.75%) |
Filing History |
| 2021-02-01 2:13 pm Purchase |
2021-01-20 | 13G | Jounce Therapeutics, Inc. JNCE |
PFM Health Sciences, LP | 2,388,067 6.000% |
2,388,067 (New Position) |
Filing History |
| 2020-11-09 4:01 pm Purchase |
2020-10-29 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 3,373,460 5.200% |
3,373,460 (New Position) |
Filing History |
| 2020-09-25 4:08 pm Purchase |
2020-09-15 | 13G | Outset Medical, Inc. OM |
PFM Health Sciences, LP | 191,533 6.800% |
191,533 (New Position) |
Filing History |